Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.12 USD | +1.15% | +0.70% | +12.95% |
May. 21 | GCM Grosvenor Invests in Healthcare Investment Firm | MT |
May. 20 | Piper Sandler Adjusts GCM Grosvenor Price Target to $10.50 From $10, Maintains Neutral Rating | MT |
Financials (USD)
Sales 2024 * | 505M | Sales 2025 * | 584M | Capitalization | 442M |
---|---|---|---|---|---|
Net income 2024 * | 17M | Net income 2025 * | 20M | EV / Sales 2024 * | 0.88 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
48.2
x | P/E ratio 2025 * |
21.5
x | Employees | 538 |
Yield 2024 * |
4.94% | Yield 2025 * |
5.76% | Free-Float | 22.86% |
Latest transcript on GCM Grosvenor Inc.
1 day | +1.15% | ||
1 week | +0.70% | ||
Current month | +7.20% | ||
1 month | +8.35% | ||
3 months | +21.20% | ||
6 months | +22.96% | ||
Current year | +12.95% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Sacks
CEO | Chief Executive Officer | 61 | 89-12-31 |
Jonathan Levin
PSD | President | 42 | 10-12-31 |
Pamela Bentley
DFI | Director of Finance/CFO | 52 | 20-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Samuel Scott
BRD | Director/Board Member | 79 | 20-10-31 |
Michael Sacks
CEO | Chief Executive Officer | 61 | 89-12-31 |
Stephen Malkin
BRD | Director/Board Member | 62 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 45 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 10.12 | +1.15% | 185,116 |
24-05-24 | 10 | +1.88% | 105,090 |
24-05-23 | 9.82 | -0.71% | 102,080 |
24-05-22 | 9.89 | -1.59% | 109,972 |
24-05-21 | 10.05 | +2.13% | 132,530 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.95% | 442M | |
+5.30% | 8.96B | |
+12.12% | 3.57B | |
-27.62% | 3.42B | |
+39.65% | 2.74B | |
+13.89% | 2.54B | |
+50.57% | 2.3B | |
+30.85% | 1.77B | |
+33.57% | 1.75B | |
+6.36% | 1.4B |
- Stock Market
- Equities
- GCMG Stock